ImmuCell Corp (NASDAQ:ICCC)

7.36
Delayed Data
As of Feb 16
 +0.0495 / +0.68%
Today’s Change
5.00
Today|||52-Week Range
9.25
-16.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues7.6M10.2M9.5M10.4M
 
 
 
 
 
Cost of Goods Sold2.7M3.5M3.3M4.3M
 
 
 
 
 
Depreciation And Amortization446.0K525.9K802.4K904.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.4M6.3M5.4M5.2M
 
 
 
 
 
General Expenses4.7M4.1M4.5M5.5M
 
 
 
 
 
Research And Development2.2M1.2M1.2M2.0M
 
 
 
 
 
Total Operating Expenses7.8M8.1M8.7M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-206.4K2.1M890.2K-243.0K
 
 
 
 
 
Interest Expense On Debt60.7K83.6K161.7K--
 
 
 
 
Other Expenses-3.9K5.6K-24.8K-195.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-255.5K2.1M758.3K-438.0K
 
 
 
 
 
Income Taxes-88.3K-850.3K-249.9K-270.0K
 
 
 
 
 
Net Income-167.2K1.2M508.4K-168.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M3.0M4.2M4.9M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M3.2M4.3M4.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06$0.38$0.12-$0.03
 
 
 
 
 
EPS Diluted-$0.06$0.38$0.12-$0.03